Retatrutide is an investigational pharmacological agent developed that functions as a triple hormone receptor agonist , targeting the glucose-dependent insulinotropic polypeptide (GIP) , glucagon-like peptide-1 (GLP-1) , and glucagon receptors
These changes protect the peptide from enzymatic breakdown and enhance its binding affinity to GHRH receptors
Cardiovascular Safety of Semaglutide in Patients with Diabetes Mellitus: A Nationwide Cohort Study. Journal of the American College of Cardiology, 71(11S), A1311
Learn more: Elsevier #neurology #neuroscience #Alzheimer #Alzheimersdisease #dementia #cognitivedecline #drugdevelopment #tau #biomarkers #precisionmedicine #Patientjourney #Clinicalcarepathway #outcomesresearch #Alzheimercare #therapy #clinicalpathways Figure
While you may think its as simple to get off Semaglutide as stopping taking your doses, quitting cold turkey isnt recommended, especially for those with type 2 diabetes